Spyre Therapeutics, Inc. SYRE Net margin
Net margin at other companies
Other financials
Where this comes from
Calculated from Spyre Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Spyre Therapeutics, Inc.’s 10-Q, filed May 8, 2025, on SEC EDGAR. View the filing →
Ask your AI about Spyre Therapeutics, Inc.'s net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Spyre Therapeutics, Inc.'s net margin?
- Spyre Therapeutics, Inc. (SYRE) reported net margin of -52,939.7% in Q1 2024.
- How has Spyre Therapeutics, Inc.'s net margin changed year-over-year?
- Spyre Therapeutics, Inc.'s net margin decreased by 692.7% year-over-year, from -6,678.2% to -52,939.7%.
- What is the long-term trend for Spyre Therapeutics, Inc.'s net margin?
- Over 2 years (2021 to 2023), Spyre Therapeutics, Inc.'s net margin has grown at a 943.5% compound annual growth rate (CAGR), from -351.1% to -38,238.1%.
- What does net margin mean?
- The share of every sales dollar that becomes bottom-line profit.
- How do you interpret net margin?
- Higher is better, but net margin mixes operating performance with financing and tax effects and one-off items — read it alongside operating margin to separate the operating story from the rest.
- How does net margin compare across companies?
- Comparable across peers but sensitive to leverage and tax structure; two operationally identical firms can show different net margins purely from financing.